Clinical Trials
9 trialsNCT02689427 2026-05-12
Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01841749 2025-09-12
CINNAMOME
Institut Bergonié
Completed
NCT00832429 2025-07-04
Lymph Node Mapping in Finding Metastatic Disease in Patients With Sebaceous Gland Cancer of the Eyelid
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00881361 2023-04-27
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT01818739 2023-03-22
Lymph Node Mapping in Patients With Endometrial Cancer
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT02910726 2022-10-05
A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers
Memorial Sloan Kettering Cancer Center
Phase 2/3 Completed
NCT00416455 2019-07-23
Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT02908178 2019-05-15
Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ
Yale University
Completed
NCT00450723 2017-02-07
Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer
University of Miami
Phase NA Completed